Carl Morris's most recent trade in Solid Biosciences Inc was a trade of 1,233 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 27, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 1,233 | 3,700 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 1,233 | 20,201 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 27 Jan 2023 | 441 | 19,760 (0%) | 0% | 7.5 | 3,303 | Common Stock |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 95,110 | 95,110 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 47,555 | 47,555 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 296,000 | 296,000 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 11,396 | 255,209 (0%) | 0% | 1.1 | 12,536 | Common Stock |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 11,269 | 266,605 (0%) | 0% | 1.1 | 12,396 | Common Stock |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 148,000 | 148,000 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 74,000 | 74,000 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.84 per share. | 12 Mar 2021 | 11,699 | 287,301 (0%) | 0% | 8.8 | 103,459 | Common Stock |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 12 Mar 2021 | 11,699 | 275,602 (0%) | 0% | 8.8 | 103,488 | Common Stock |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 302,459 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 0 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 27 Jan 2021 | 3,459 | 299,000 (0%) | 0% | 6.1 | 21,238 | Common Stock |
Solid Biosciences Inc | Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 175,000 | 175,000 | - | - | Employee Stock Option (Right to Buy) |